A Study of Amygdala Retraining Program in Patients with Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia

Overview

About this study

The purpose of this study is to gather preliminary data on the effectiveness and feasibility of the Amygdala Retraining Program, a mind-body practice, on fatigue, quality of life and sleep in patients with Chronic Fatigue Syndrome, Chronic Fatigue, and Fibromyalgia.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Meets CDC criteria for Chronic Fatigue Syndrome, has been diagnosed with chronic fatigue, or meets the American College of Rheumatology criteria for fibromyalgia

Exclusion Criteria

  • Untreated hypo or hyper thyroidism
  • Untreated hypo or hyper parathyroidism
  • Untreated adrenal disorders
  • Untreated diabetes
  • Multiple sclerosis
  • Acute or chronic hepatitis
  • History of cancer
  • Untreated depression
  • Chronic steroid use
  • Acute inflammatory rheumatological conditions
  • Untreated obstructive sleep apnea
  • Narcolepsy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ann Vincent, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20312908

Mayo Clinic Footer